Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 500 entries
View as:

Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00383721 Org: User:
Start: 09/30/06 End: 07/31/10 Due: 07/31/11

Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00988260 Org: User:
Start: 02/03/03 End: 04/12/04 Due: 04/12/05

This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00491504 Org: User:
Start: 02/28/07 End: 07/31/07 Due: 07/31/08

Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00635882 Org: User:
Start: 02/29/08 End: 06/30/09 Due: 06/30/10

Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)

Phase: N/A Priority: Normal
NCT ID: NCT00696878 Org: User:
Start: 09/26/06 End: 05/15/09 Due: 05/15/10

Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)

Phase: N/A Priority: Normal
NCT ID: NCT03768427 Org: User:
Start: 05/27/19 End: 04/01/21 Due: 04/01/22

A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1)

Phase: N/A Priority: Normal
NCT ID: NCT01333436 Org: User:
Start: 07/20/11 End: 05/12/12 Due: 05/12/13

Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)

Phase: N/A Priority: Normal
NCT ID: NCT00783146 Org: User:
Start: 08/01/04 End: 10/01/04 Due: 10/01/05

Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)

Phase: N/A Priority: Normal
NCT ID: NCT00764478 Org: User:
Start: 04/06/12 End: 05/28/14 Due: 05/28/15

A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)

Phase: N/A Priority: Normal
NCT ID: NCT01617187 Org: User:
Start: 12/04/12 End: 09/09/14 Due: 09/09/15

Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00653913 Org: User:
Start: 03/31/04 End: 09/30/04 Due: 09/30/05

An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00599027 Org: User:
Start: 05/31/08 End: 05/31/09 Due: 05/31/10

To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00271817 Org: User:
Start: 12/31/05 End: 02/29/08 Due: 02/28/09

Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442)

Phase: N/A Priority: Normal
NCT ID: NCT00805584 Org: User:
Start: 05/31/03 End: 06/30/03 Due: 06/30/04

Obese Hypertension Study (0954-315)

Phase: N/A Priority: Normal
NCT ID: NCT00289887 Org: User:
Start: 02/28/06 End: 03/31/07 Due: 03/31/08

Livial Intervention Following Breast Cancer; Efficacy, Recurrence and Tolerability Endpoints (LIBERATE)(COMPLETED)(P05885)

Phase: N/A Priority: Normal
NCT ID: NCT00408863 Org: User:
Start: 05/31/02 End: 10/31/07 Due: 10/31/08

Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)

Phase: N/A Priority: Normal
NCT ID: NCT01916980 Org: User:
Start: 08/27/13 End: 03/22/14 Due: 03/22/15

Evaluation of Participant Responses to Educational Counseling About Different Combined Hormonal Contraceptive Choices (P06557)

Phase: N/A Priority: Normal
NCT ID: NCT01181778 Org: User:
Start: 10/31/10 End: 10/31/12 Due: 10/31/13

An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00092677 Org: User:
Start: 01/31/01 End: 04/30/08 Due: 04/30/09

40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)

Phase: N/A Priority: Normal
NCT ID: NCT00145509 Org: User:
Start: 08/31/05 End: 12/31/07 Due: 12/31/08

Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519)

Phase: N/A Priority: Normal
NCT ID: NCT01857063 Org: User:
Start: 06/10/13 End: 09/01/13 Due: 09/01/14

Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)

Phase: N/A Priority: Normal
NCT ID: NCT01615874 Org: User:
Start: 01/31/13 End: 09/30/13 Due: 09/30/14

A Study of Etoricoxib in Participants With Osteoarthritis Not Responding to Analgesic Drugs (MK-0663-142)

Phase: N/A Priority: Normal
NCT ID: NCT01429168 Org: User:
Start: 10/31/11 End: 08/31/12 Due: 08/31/13

Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT04042103 Org: User:
Start: 07/23/19 End: 01/09/20 Due: 01/09/21

Exercise Induced Bronchoconstriction (0476-359)

Phase: N/A Priority: Normal
NCT ID: NCT00664937 Org: User:
Start: 05/31/07 End: 10/31/08 Due: 10/31/09